ID18568A - HYDROFOB AVAILABILITY THAT CONTAINS MIDDLE CHAIN MONOGLISERIDES - Google Patents

HYDROFOB AVAILABILITY THAT CONTAINS MIDDLE CHAIN MONOGLISERIDES

Info

Publication number
ID18568A
ID18568A IDP972303A ID972303A ID18568A ID 18568 A ID18568 A ID 18568A ID P972303 A IDP972303 A ID P972303A ID 972303 A ID972303 A ID 972303A ID 18568 A ID18568 A ID 18568A
Authority
ID
Indonesia
Prior art keywords
monogliserides
hydrofob
availability
middle chain
contains middle
Prior art date
Application number
IDP972303A
Other languages
Indonesian (id)
Inventor
New Roger Randal Charles
Kirbi Christopher John
Original Assignee
Correcs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Correcs Ltd filed Critical Correcs Ltd
Publication of ID18568A publication Critical patent/ID18568A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
IDP972303A 1996-07-02 1997-07-02 HYDROFOB AVAILABILITY THAT CONTAINS MIDDLE CHAIN MONOGLISERIDES ID18568A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613858.1A GB9613858D0 (en) 1996-07-02 1996-07-02 Hydrophobic preparations

Publications (1)

Publication Number Publication Date
ID18568A true ID18568A (en) 1998-04-23

Family

ID=10796214

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972303A ID18568A (en) 1996-07-02 1997-07-02 HYDROFOB AVAILABILITY THAT CONTAINS MIDDLE CHAIN MONOGLISERIDES

Country Status (13)

Country Link
US (1) US6258377B1 (en)
EP (1) EP0910411A1 (en)
JP (1) JP2000515130A (en)
KR (1) KR20000022353A (en)
AU (1) AU709013B2 (en)
BR (1) BR9710179A (en)
CA (1) CA2259233A1 (en)
GB (1) GB9613858D0 (en)
ID (1) ID18568A (en)
NO (1) NO986211L (en)
NZ (1) NZ333115A (en)
WO (1) WO1998000169A1 (en)
ZA (1) ZA975856B (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731909B2 (en) 1997-07-01 2001-04-05 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
AU745880B2 (en) 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
CN1329502A (en) * 1998-12-04 2002-01-02 普罗瓦利斯英国有限公司 Pharmaceutical compositions containing insulin
TR200200562T2 (en) 1999-06-14 2002-05-21 Cosmo S.P.A Pharmaceutical compositions for oral release that can be secreted in the body in a controlled manner and prevent unpleasant taste
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
GB2355009A (en) 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
CN1255095C (en) * 1999-10-08 2006-05-10 科蒂股份有限公司 Cosmetic preparation of active substances with synergistically increased radical protection factor
US20030054015A1 (en) * 2000-12-25 2003-03-20 Shinichiro Haze Sympathetic-activating perfume composition
KR100508695B1 (en) * 2001-02-13 2005-08-17 한국과학기술연구원 Formulation for oral delivery of insulin and preparation method thereof
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
CN1160122C (en) 2001-04-20 2004-08-04 清华大学 Method of preparing oil-phase oral insulin preparation
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
GB0308734D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Uptake of macromolecules
GB0308732D0 (en) * 2003-04-15 2003-05-21 Axcess Ltd Absorption enhancers
WO2005092370A1 (en) 2004-03-22 2005-10-06 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
CA2910494C (en) 2004-07-19 2018-10-23 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
DE602007009377D1 (en) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc SECONDARY FLOW MODULATOR WITH AN INTERNAL CHANNEL FOR AN OSMOTIC OUTPUT SYSTEM
US8940719B2 (en) * 2006-07-03 2015-01-27 Academia Sinica Lithocholic acid analogues that inhibit sialyltransferase
KR101200728B1 (en) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 Osmotic delivery system and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
MX2010003979A (en) 2007-10-16 2010-06-02 Biocon Ltd An orally administerable solid pharmaceutical composition and a process thereof.
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
CN102112110A (en) * 2008-06-06 2011-06-29 米尔纳医疗股份有限公司 Novel compositions for the in vivo delivery of RNAi agents
WO2010113177A2 (en) 2009-03-31 2010-10-07 Reliance Life Sciences Pvt. Ltd. Oral insulin delivery systems for controlling diabetes
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
EP2380920A1 (en) 2010-04-22 2011-10-26 QGel SA Hydrogel precursor formulation and production process thereof
EP2594281B1 (en) 2010-07-14 2019-08-28 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Insulin-lipid complex, preparation method therefor, and preparation thereof
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
GB201107630D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
JP6243331B2 (en) 2012-05-31 2017-12-06 テルモ株式会社 PH-SENSITIVE CARRIER AND METHOD FOR PRODUCING SAME, PH-SENSITIVE MEDICINE CONTAINING THE CARRIER, pH-SENSITIVE PHARMACEUTICAL COMPOSITION AND CULTURE METHOD USING THE SAME
RU2677346C2 (en) * 2013-01-14 2019-01-16 ИнФерст Хэлткэр Лимитед Compositions and methods for treating severe pain
EP2925367B1 (en) * 2013-01-14 2019-08-14 InFirst Healthcare Limited Solid solution compositions and use in chronic inflammation
CA2898017A1 (en) * 2013-02-04 2014-08-07 Infirst Healthcare Limited Compositions and methods for treating chronic inflammation and inflammatory diseases
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (en) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 Implant placement and removal systems
MA53353A (en) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc GLUCAGON RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS FOR THEIR USE
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
ATE2688T1 (en) 1979-06-11 1986-03-15 Gebrueder Sulzer Aktiengesellschaft LOOKING THREAD FEED DEVICE FOR A LOOPPING MACHINE.
JP2556865B2 (en) * 1986-09-19 1996-11-27 山之内製薬株式会社 Composition for non-injection administration of neocarzinostatin derivative
EP0597007B1 (en) * 1991-07-26 1996-10-16 Smithkline Beecham Corporation W/o microemulsions
JPH08502490A (en) * 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション Composition
WO1994008605A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Therapeutic microemulsions
GB9224502D0 (en) * 1992-11-23 1993-01-13 New Roger R C Method of preparing a lipid-containing formulation
EP0684834A4 (en) * 1993-02-17 1996-09-25 Smithkline Beecham Corp Microemulsions comprising therapeutic peptides.
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
GB9422990D0 (en) 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
GB9424901D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents
GB9424902D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids
GB9605709D0 (en) 1996-03-19 1996-05-22 Cortecs Ltd Method

Also Published As

Publication number Publication date
BR9710179A (en) 1999-08-10
WO1998000169A1 (en) 1998-01-08
EP0910411A1 (en) 1999-04-28
NO986211L (en) 1999-03-02
NZ333115A (en) 2000-06-23
GB9613858D0 (en) 1996-09-04
ZA975856B (en) 1999-01-04
AU3352697A (en) 1998-01-21
KR20000022353A (en) 2000-04-25
CA2259233A1 (en) 1998-01-08
JP2000515130A (en) 2000-11-14
US6258377B1 (en) 2001-07-10
NO986211D0 (en) 1998-12-30
AU709013B2 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
ID18568A (en) HYDROFOB AVAILABILITY THAT CONTAINS MIDDLE CHAIN MONOGLISERIDES
ID26509A (en) COMPONENTS THAT CONTAIN TETRAHIDROLIPSTATIN
ID28110A (en) ALFYLBENZENASULFONATE SURFACTED ENHANCED
ID17427A (en) Wear once
ID17346A (en) Wear once
ID18096A (en) Wear once
ID17545A (en) Wear once
ID18374A (en) Wear once
ID21018A (en) Wear once
ID20043A (en) Wear once
ID21602A (en) Wear once
ID26330A (en) VITAMIN K MODIFICATED POLIPEPTIDES
DE69736787D1 (en) Caterpillar
ID20975A (en) Wear once
ID21197A (en) Wear once
DE59704861D1 (en) Strap
ID17571A (en) Wear once
ID21770A (en) PLESTER THAT CONTAINS FELBINAK
DE59707140D1 (en) cycloidal
ID18448A (en) Wear once
ID16287A (en) Wear once
PT811522E (en) TRACCAO MULTICTORRENTES CHAIN
ID16288A (en) Wear once
DE29623367U1 (en) Caterpillar
ID16390A (en) Wear once